PUBLISHING MODELUnderstanding Cureus and Its Place in Medical Literature

Cureus occupies a distinctive niche in the medical publishing ecosystem. Launched in 2009, the journal was designed from the ground up as a digital-native, open-access platform with a streamlined peer-review process intended to reduce the time from submission to publication. Unlike traditional subscription-based medical journals with their lengthy review cycles and limited accessibility, Cureus prioritizes rapid dissemination of clinical observations, case reports, and small-scale studies that might otherwise struggle to find a publication venue.

An Impact Factor of 0.8 with a Q3 ranking in the Medicine category positions the journal as a mid-tier option in the vast medical publishing landscape. While this figure does not compete with the elite clinical journals that command Impact Factors in double digits, it represents a functional baseline for a general medical journal with an open-access model and relatively high acceptance rates. The journal’s value proposition lies not in exclusivity but in accessibility, both for authors seeking to publish without lengthy delays and for readers in resource-limited settings who lack subscription access to premium titles.

METRICS OVERVIEWPerformance Indicators

CRITICAL ASSESSMENTContextualizing 0.8 in Medical Publishing

The general Medicine category in JCR encompasses thousands of journals ranging from sub-specialty titles with small readerships to major general medical journals with global influence. With an Impact Factor of 0.8, Cureus sits comfortably above the bottom quartile while remaining below the elite tier. This positioning is entirely consistent with the journal’s editorial philosophy, which emphasizes volume, speed, and inclusivity over selective prestige.

The CiteScore of 1.2 from Scopus tracks slightly above the Impact Factor, suggesting that articles accumulate some additional citations in the third and fourth years after publication. The SJR of 0.35 indicates that citing journals are of moderate prestige, while the h-index of 35 reflects a growing body of papers that have achieved meaningful citation counts. For a journal founded in 2009, these metrics represent acceptable progress in a medical publishing market that is both crowded and highly stratified.